NanoCross™ Elite AB14W060200150 (UDI 00763000758349)Recalls & reported problems
Medtronic, Inc. · PTA AB14W060200150 NANOCROSS 014 V06 · Class 2
All models of NanoCross Elite (31)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00763000758349), received between Oct 2, 2024 and Jun 26, 2025 — classified as 3 malfunctions.
The most frequently reported specific device problem is “Burst Container or Vessel” (1 report).
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Recalls naming this device
- Dec 10, 2024Class IIOpen, Classified
There is the potential for in-vivo balloon deflation issues, including difficulty or inability to deflate the balloon in specific lots.
Z-0904-2025 · Root cause: Process change control · Recall details · FDA record ↗
Most reported problems
Device problems
- Burst Container or Vessel1
- Deflation Problem1
- Delivered as Unsterile Product1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionJun 26, 2025Delivered as Unsterile Product; Delivered as Unsterile Product
IT WAS REPORTED THAT THE NANOCROSS ELITE OUTER PACKAGE WAS DAMAGED, AND A TEAR IN THE PACKAGING. THE STERILE PACKAGING WAS NOT INTACT. THE DAMAGE WAS IDENTIFIED DURING PRODUCT RECEIPT, AND THE DEVICE WAS NOT USED IN A PATIENT. THERE WAS NO PATIENT INVOLVED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22334484 ↗MalfunctionJun 19, 2025Burst Container or Vessel; Burst Container or Vessel
IT WAS REPORTED THAT DURING A PROCEDURE INVOLVING THE NANOCROSS ELITE, THE BALLOON BURST ON THE FIRST INFLATION WHILE BEING USED IN THE SUPERFICIAL FEMORAL ARTERY. THE DEVICE WAS SAFELY REMOVED FROM THE PATIENT AND THERE WAS NO INJURY/INTERVENTION ASSOCIATED WITH THIS EVENT. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22291777 ↗MalfunctionOct 2, 2024Deflation Problem; Deflation Problem
PHYSICIAN ATTEMPTED TO USE A NANOCROSS ELITE PTA BALLOON WITH A 6FR NON-MEDTRONIC (COOK) SHEATH AND A .014 NON-MEDTRONIC (CHOICEPT) GUIDEWIRE DURING TREATMENT OF A 250MM CALCIFIED LESION IN THE PATIENT¿S LEFT MID SUPERFICIAL FEMORAL ARTERY. MINIMAL TORTUOSITY ANDSEVERE CALCIFICATION WERE REPORTED. LESION EXHIBITED 70% STENOSIS. ARTERY DIAMETER REPORTED AS 6MM. THERE WERE NO ABNORMALITIES REPORTED IN RELATION TO ANATOMY. THERE WAS NO DAMAGE NOTED TO PACKAGING, I.E. SHELF CARTON, HOOP/TRAY. NO ISSUES WERE NOTED WHEN REMOVING THE DEVICE FROM THE HOOP/TRAY. THE IFU (INSTRUCTION FOR USE) WAS FOLLOWED DURING PREPARATION, PROCEDURE, POST-PROCEDURE WITHOUT ISSUE. EMBOLIC PROTECTION WAS NOT USED. THE VESSEL WAS PRE AND POST DILATED. A NON-MEDTRONIC (AC3200) INFLATION DEVICE WAS USED. 50/50 CONTRAST FLUID WAS USED. THE BALLOON WAS NOT PASSED THROUGH A PREVIOUSLY DEPLOYED STENT. NO RESISTANCE WAS NOTED DURING ADVANCEMENT OF THE DEVICE. DEFLATION DIFFICULTIES WERE REPORTED. AFTER 5 MINUTES AND MULTIPLE ATTEMPTS AT APPLYING NEGATIVE PRESSURE THE BALLOON EVENTUALLY DEFLATED. THE DEVICE WAS SAFELY REMOVED AND A NEW NANOCROSS 6X200 DEVICE WAS USED TO COMPLETE THE PROCEDURE. NO PATIENT INJURY REPOR
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20352044 ↗
Other Catheter, angioplasty, peripheral, transluminal devices
- Coyote™ ES H74939135152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal879 reports
- Coyote™ ES H74939135204010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal585 reports
- Coyote™ ES H74939135202010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal437 reports
- Coyote™ ES H74939135304010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal384 reports
- Coyote™ ES H74939135404010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal293 reports
- Coyote™ ES H74939134152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal279 reports
- Coyote™ H74939185202210Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal200 reports
- Coyote™ ES H74939135254010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal127 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page